Noncoding RNAs in Cardiac Hypertrophy and Heart Failure
Heart failure is a major global health concern. Noncoding RNAs (ncRNAs) are involved in physiological processes and in the pathogenesis of various diseases, including heart failure. ncRNAs have emerged as critical components of transcriptional regulatory pathways that govern cardiac development, str...
Main Authors: | Peilei Lu, Fan Ding, Yang Kevin Xiang, Liying Hao, Meimi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/5/777 |
Similar Items
-
Ferroptosis in cardiac hypertrophy and heart failure
by: Kuo Zhang, et al.
Published: (2023-12-01) -
Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development
by: Alfredo Caturano, et al.
Published: (2022-05-01) -
Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
by: Jimmonique Donelson, et al.
Published: (2019-04-01) -
Role of Exosomal miRNAs in Heart Failure
by: Ruicong Xue, et al.
Published: (2020-12-01) -
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
by: Youchen Yan, et al.
Published: (2022-03-01)